These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16151336

  • 21. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG, Langley RG, Finlay AY, Griffiths CE, Woolley JM, Lalla D, Jahreis A.
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
    Weinberg JM.
    Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953
    [Abstract] [Full Text] [Related]

  • 26. Cochlin in autoimmune inner ear disease: is the search for an inner ear autoantigen over?
    Baruah P.
    Auris Nasus Larynx; 2014 Dec; 41(6):499-501. PubMed ID: 25199741
    [Abstract] [Full Text] [Related]

  • 27. Etanercept as monotherapy in patients with psoriasis.
    Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, Etanercept Psoriasis Study Group.
    N Engl J Med; 2003 Nov 20; 349(21):2014-22. PubMed ID: 14627786
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
    Gordon K, Korman N, Frankel E, Wang H, Jahreis A, Zitnik R, Chang T.
    J Am Acad Dermatol; 2006 Mar 20; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 Mar 20; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 33. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
    Weisman MH, Paulus HE, Burch FX, Kivitz AJ, Fierer J, Dunn M, Kerr DR, Tsuji W, Baumgartner SW.
    Rheumatology (Oxford); 2007 Jul 20; 46(7):1122-5. PubMed ID: 17470434
    [Abstract] [Full Text] [Related]

  • 34. A randomized trial of etanercept as monotherapy for psoriasis.
    Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, Gaspari AA, Ling M, Weinstein GD, Nayak A, Gordon KB, Zitnik R.
    Arch Dermatol; 2003 Dec 20; 139(12):1627-32; discussion 1632. PubMed ID: 14676082
    [Abstract] [Full Text] [Related]

  • 35. [A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis].
    Huang F, Zhang J, Zheng Y, Xu JH, Li XF, Wu HX, Chen ZW, Zhao Z, Zhang YM.
    Zhonghua Nei Ke Za Zhi; 2011 Dec 20; 50(12):1043-7. PubMed ID: 22333175
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
    Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R, OPT Compare Investigators.
    Lancet; 2015 Aug 08; 386(9993):552-61. PubMed ID: 26051365
    [Abstract] [Full Text] [Related]

  • 38. Use of biologics for treatment of autoimmune inner ear disease.
    Balouch B, Meehan R, Suresh A, Zaheer HA, Jabir AR, Qatanani AM, Suresh V, Kaleem SZ, McKinnon BJ.
    Am J Otolaryngol; 2022 Aug 08; 43(5):103576. PubMed ID: 35963108
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G, Spanò F, Contatore M, Guastalla A, Magnani O, Puppo F.
    Expert Opin Drug Saf; 2014 May 08; 13(5):649-61. PubMed ID: 24654562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.